Paladin Pharma Email Format
Pharmaceutical ManufacturingQuebec, Canada51-200 Employees
Paladin Pharma is a mid-sized specialty pharmaceutical company based in Montréal, Quebec, focused on bringing emerging medicines to the Canadian market by acquiring or licensing rights. It operates as an entity within Endo, a diversified organization that emphasizes development, manufacturing, and commercialization of medicines. The firm serves Canadian pharmaceutical developers seeking access to new therapies and, by extension, patients who may benefit from innovative treatments, supported by a dedicated workforce. One notable development in its recent history is a 2024 license arrangement with MC2 Therapeutics to bring WYNZORA to Canada. This type of collaboration illustrates Paladin's role in connecting developers of specialty medicines with the Canadian healthcare system.